Source:http://linkedlifedata.com/resource/pubmed/id/10078971
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-5-6
|
pubmed:abstractText |
This study addresses two issues: (1) the comparative neurochemistry of classic tremor type of Parkinson's disease or PD-A and akinetic type of Parkinson's disease or PD-B; and (2) the neurochemistry of levodopa failure syndrome (LDFS). Cerebrospinal fluid from the lateral ventricle was collected from 50 patients with idiopathic Parkinson's disease of PD-A and PD-B. Levels of monoamine neurotransmitters and metabolites were determined using high performance liquid chromatography. We have found that (1) 5-hydroxylindoleacetic acid (5-HIAA) level is significantly lower in PD-B than in PD-A; (2) 5-HIAA level is inversely associated with score of part one of United Parkinson's Disease Rating Score (UPDRS); (3) 5-HIAA level is inversely associated with score of part four of UPDRS; (4) 3-O-methyldopa (3-OMD) level is positively associated with levodopa failure syndrome (LDFS) assessed by part four of UPDRS and inversely associates with 5-HIAA. From these data, it can be inferred that serotonergic activity is decreased in PD-B to a greater extent than in PD-A and that decreased serotonergic activity plays a role in LDFS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-methoxytyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/Antiparkinson Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0969-9961
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10078971-Aged,
pubmed-meshheading:10078971-Antiparkinson Agents,
pubmed-meshheading:10078971-Brain Chemistry,
pubmed-meshheading:10078971-Chromatography, High Pressure Liquid,
pubmed-meshheading:10078971-Disease Progression,
pubmed-meshheading:10078971-Dopamine,
pubmed-meshheading:10078971-Female,
pubmed-meshheading:10078971-Humans,
pubmed-meshheading:10078971-Hydroxyindoleacetic Acid,
pubmed-meshheading:10078971-Levodopa,
pubmed-meshheading:10078971-Male,
pubmed-meshheading:10078971-Middle Aged,
pubmed-meshheading:10078971-Parkinson Disease,
pubmed-meshheading:10078971-Tyrosine
|
pubmed:year |
1999
|
pubmed:articleTitle |
A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease.
|
pubmed:affiliation |
Department of Pharmacology/Physiology, Loma Linda University Medical School, California 92350, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|